Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

NCT01163084 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage IIA Prostate Cancer AJCC v7
Stage IIB Prostate Cancer AJCC v7

Interventions

DRUG: Goserelin Acetate
OTHER: Laboratory Biomarker Analysis
DRUG: Leuprolide Acetate
DRUG: Vismodegib

Sponsor

National Cancer Institute (NCI)